Connection

Jean-Sébastien Hulot to Genetic Therapy

Back to Details
This is a "connection" page, showing publications Jean-Sébastien Hulot has written about Genetic Therapy.
Jean-Sébastien Hulot
Connection Strength
0.478
Genetic Therapy
  1. Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial. Eur J Heart Fail. 2017 11; 19(11):1534-1541.
    View in: PubMed
    Score: 0.478
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.